About the Company
harvard bioscience is a global developer, manufacturer and marketer of a broad range of specialized products, primarily apparatus and scientific instruments used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories worldwide. we sell our products to thousands of researchers in over 100 countries through our full-line catalog (and various other specialty catalogs), our websites, and through distributors, including ge healthcare, thermo fisher scientific inc., and vwr. we have sales and manufacturing operations in the united states, the united kingdom, germany, and spain and sales facilities in france and canada.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $HBIO News
Harvard Bioscience Inc (HBIO) Reports Mixed Fourth Quarter and Full Year 2023 Results
On March 7, 2024, Harvard Bioscience Inc (NASDAQ:HBIO) released its 8-K filing, announcing the financial results for the ...
Is There An Opportunity With Harvard Bioscience, Inc.'s (NASDAQ:HBIO) 34% Undervaluation?
The projected fair value for Harvard Bioscience is US$6.70 based on 2 Stage Free Cash Flow to Equity Harvard Bioscience's ...
Harvard Bioscience Inc HBIO
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Harvard Bioscience, Inc. (HBIO) Q4 2023 Earnings Call Transcript
Good morning, and thank you for standing by. Welcome to Harvard Bioscience, Inc. Fourth Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the ...
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
HOLLISTON, Mass., March 07, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the fourth quarter and year ended December 31 ...
Harvard Bioscience: Q4 Earnings Snapshot
Harvard Bioscience Inc. (HBIO) on Thursday reported a loss of $1.8 million in its fourth quarter. The Holliston, Massachusetts-based company said it had a loss of 4 cents per share. Earnings, adjusted ...
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that it will be showcasing its latest product innovations at the Society of Toxicology (SOT) conference from March 11-13, 2024, in Salt Lake ...
Harvard Bioscience Inc.
Picking the best bond ETF can be hard with so many options available. Here's what the experts suggest focusing on. Marijuana ETFs have had it rough lately, but risk-tolerant investors can tap ...
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
HOLLISTON, Mass., March 07, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the fourth quarter and year ...
Harvard Bioscience: Q4 Earnings Snapshot
HOLLISTON, Mass. (AP) — HOLLISTON, Mass. (AP) — Harvard Bioscience Inc. (HBIO) on Thursday reported a loss of $1.8 million in its fourth quarter. The Holliston, Massachusetts-based company ...
Harvard Bioscience, Inc.: Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
Q4 operating income of $0.3 million, adjusted operating income of $3.3 millionStrong operating cash flow enabled ...
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the fourth quarter and year ended December 31, 2023. Jim Green, Chairman and CEO said ...
Loading the latest forecasts...